These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders. Yoshimura R, Nakano Y, Hori H, Ikenouchi A, Ueda N, Nakamura J. Hum Psychopharmacol; 2006 Oct; 21(7):433-8. PubMed ID: 17029305 [Abstract] [Full Text] [Related]
12. Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients. Yoshimura R, Ueda N, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Nakamura J. World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):256-61. PubMed ID: 20218790 [Abstract] [Full Text] [Related]
13. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Xu Q, Shen Y, Haile CN, Kosten TA, Kosten TR. J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017 [Abstract] [Full Text] [Related]
14. Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients. Yasui-Furukori N, Saito M, Nakagami T, Furukori H, Suzuki A, Kondo T, Kaneko S. J Psychopharmacol; 2010 Jul; 24(7):987-94. PubMed ID: 19477882 [Abstract] [Full Text] [Related]
16. Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone. Yasui-Furukori N, Tsuchimine S, Saito M, Nakagami T, Sugawara N, Fujii A, Kaneko S. J Clin Psychopharmacol; 2011 Oct; 31(5):633-7. PubMed ID: 21869689 [Abstract] [Full Text] [Related]
17. Effects of antipsychotics on the serum BDNF levels in schizophrenia. Chen CC, Huang TL. Psychiatry Res; 2011 Oct 30; 189(3):327-30. PubMed ID: 21320726 [Abstract] [Full Text] [Related]